Navigation Links
TPI to Host Fiscal Year 2013 Earnings Conference Call on Friday, September 27th, 2013 at 9 a.m. ET

CHENGDU, China, Sept. 19, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the fiscal year 2013 ending June 30, 2013 to be held at 9:00 a.m. ET on Friday, September 27th, 2013.

Interested parties may access the call by dialing:

TOLL-FREE    1-877-941-2068
TOLL/INTERNATIONAL    1-480-629-9712

The conference ID is 4640745. It is advisable to dial in approximately 5 minutes prior to the start of the call.

A replay will be available by calling:

TOLL-FREE   1-877-870-5176
TOLL/INTERNATIONAL   1-858-384-5517

From:  09/27/13 @ 12:00 pm Eastern Time
To:    10/11/13 @ 11:59 pm Eastern Time
Replay Pin Number:  4640745

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at the following link:

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 10 are included in the essential drug list (EDL) of China. TPI's pipeline targets various high incidence healthcare indications. For more information about TPI, please visit:

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit:, or email:

Tel:     +86-28-8551-6696 (Chengdu, China)

            +86-134-3655-0011 (China)


Tianyin Pharmaceutical

23rd Floor, Unionsun Yangkuo Plaza     

No. 2, Block 3, South Renmin Road

Chengdu, 610041


Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results
2. Apollo Medical Holdings Reports Record Fiscal 2014 Second Quarter Results
3. Unilife Corporation Announces Financial Results For Fiscal Year 2013 Fourth Quarter
4. Tekni-Plex, Inc. To Hold Teleconference To Discuss Financial Results For Fiscal Year 2013 On September 12, 2013
5. Unilife Corporation To Announce Financial Results For Fiscal Year 2013 Fourth Quarter And Year End On Tuesday, September 10, 2013
6. Accuray Announces Results for Fourth Quarter and Fiscal Year 2013
7. China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013
8. Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue and Earnings
9. Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
10. CareFusion Reports Fourth Quarter And Fiscal 2013 Results
11. Cyberonics To Report Fiscal Year 2014 First Quarter Results And Host Webcast And Conference Call On August 22, 2013
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
(Date:11/25/2015)... Asia -based venture ... and the New Investors will make a direct equity ... private placement. The financing will help IOPtima to continue ... in the treatment of glaucoma, as well as to ... system with the U.S. Food and Drug Administration, commencing ...
(Date:11/25/2015)... , November 25, 2015 Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ... and regulatory/legal strategies all play a key ... says GBI Research . --> ... a key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy ... personal heating products business. Cozy Products explains what this means for business moving ... well with the Cozy Products business model: to sell personal heaters that reduce energy ...
Breaking Medicine News(10 mins):